Outcomes and Utility of TTR Reporting in the Colorado Center for Personalized Medicine Biobank

被引：0
|
作者：
Crooks, K. [1 ]
Axell, L. [1 ]
Kao, D. [1 ]
Ku, L. [1 ]
Rafaels, N. [1 ]
Shortt, J. [1 ]
Todd, E. [1 ]
机构：
[1] Univ Colorado, Aurora, CO USA
来源：
JOURNAL OF MOLECULAR DIAGNOSTICS | 2023年 / 25卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
G007
引用
收藏
页码：S3 / S3
页数：1
相关论文
共 50 条
  • [31] Economic analyses of genetic tests in personalized medicine: clinical utility first, then cost utility
    Grosse, Scott D.
    GENETICS IN MEDICINE, 2014, 16 (03) : 225 - 227
  • [32] THL Biobank, an infrastructure for multi-omics systems biology and personalized medicine studies
    Marjonen, Heidi
    Joensuu, Anni
    Kantojarvi, Katri
    Silander, Kaisa
    Perola, Markus
    Soini, Sirpa
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2022, 30 (SUPPL 1) : 507 - 507
  • [33] The Information Technology Infrastructure for the Translational Genomics Core and the Partners Biobank at Partners Personalized Medicine
    Boutin, Natalie
    Holzbach, Ana
    Mahanta, Lisa
    Aldama, Jackie
    Cerretani, Xander
    Embree, Kevin
    Leon, Irene
    Rathi, Neeta
    Vickers, Matilde
    JOURNAL OF PERSONALIZED MEDICINE, 2016, 6 (01): : 1 - 6
  • [34] The Colorado Violent Death Reporting System (COVDRS): Validity and Utility of the Veteran Status Variable
    Bahraini, Nazanin H.
    Gutierrez, Peter M.
    Harwood, Jeri E. F.
    Huggins, Joe A.
    Hedegaard, Holly
    Chase, Mary
    Brenner, Lisa A.
    PUBLIC HEALTH REPORTS, 2012, 127 (03) : 304 - 309
  • [35] miRNAs in drug response variability: potential utility as biomarkers for personalized medicine
    Latini, Andrea
    Borgiani, Paola
    Novelli, Giuseppe
    Ciccacci, Cinzia
    PHARMACOGENOMICS, 2019, 20 (14) : 1049 - 1059
  • [36] Personalized medicine policy challenges: measuring clinical utility at point of care
    van Rooij, Tibor
    Wilson, Donna M.
    Marsh, Sharon
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2012, 12 (03) : 289 - 295
  • [37] Implications of personalized medicine-perspective from a cancer center
    Tursz, Thomas
    Andre, Fabrice
    Lazar, Vladimir
    Lacroix, Ludovic
    Soria, Jean-Charles
    NATURE REVIEWS CLINICAL ONCOLOGY, 2011, 8 (03) : 177 - 183
  • [38] Development of a living organoid biobank derived from colorectal cancer patients: Towards personalized medicine
    Papaccio, F.
    Gutierrez-Bravo, M. F.
    Cabeza-Segura, M.
    Gambardella, V.
    Huerta, M.
    Martinez Ciarpaglini, C.
    Rosello Keranen, S.
    Gimeno-Valiente, F.
    Fleitas, T.
    Tarazona Llavero, N.
    Roda, D.
    Cervantes, A.
    Castillo, J.
    ANNALS OF ONCOLOGY, 2019, 30
  • [39] Development of a large-scale de-identified DNA biobank to enable personalized medicine
    Roden, D. M.
    Pulley, J. M.
    Basford, M. A.
    Bernard, G. R.
    Clayton, E. W.
    Balser, J. R.
    Masys, D. R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 84 (03) : 362 - 369
  • [40] TRANSTHYRETIN (TTR) DNA ANALYSIS: EXPERIENCE OF THE INDIANA UNIVERSITY SCHOOL OF MEDICINE AMYLOID RESEARCH CENTER
    Benson, M. D.
    Hardwick, J.
    Michael, M.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2015, 20 (02) : 104 - 104
12345